Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
about
Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of cisplatinum/pacl ...... amous cell carcinoma patients.
@en
Comparison of cisplatinum/pacl ...... amous cell carcinoma patients.
@nl
type
label
Comparison of cisplatinum/pacl ...... amous cell carcinoma patients.
@en
Comparison of cisplatinum/pacl ...... amous cell carcinoma patients.
@nl
prefLabel
Comparison of cisplatinum/pacl ...... amous cell carcinoma patients.
@en
Comparison of cisplatinum/pacl ...... amous cell carcinoma patients.
@nl
P2093
P2860
P356
P1476
Comparison of cisplatinum/pacl ...... amous cell carcinoma patients.
@en
P2093
Guofang Hu
Qingqing Zhang
Zhehai Wang
P2860
P304
P356
10.2147/DDDT.S105441
P407
P577
2016-07-01T00:00:00Z